Cargando…
Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery
Recent advances in techniques to differentiate human induced pluripotent stem cells (hiPSCs) hold the promise of an unlimited supply of human derived cardiac cells from both healthy and disease populations. That promise has been tempered by the observation that hiPSC-derived cardiomyocytes (hiPSC-CM...
Autores principales: | Feric, Nicole T, Pallotta, Isabella, Singh, Rishabh, Bogdanowicz, Danielle R, Gustilo, Marietta M, Chaudhary, Khuram W, Willette, Robert N, Chendrimada, Tim P, Xu, Xiaoping, Graziano, Michael P, Aschar-Sobbi, Roozbeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813749/ https://www.ncbi.nlm.nih.gov/pubmed/31385592 http://dx.doi.org/10.1093/toxsci/kfz168 |
Ejemplares similares
-
Biowire: a new platform for maturation of human pluripotent stem cell derived cardiomyocytes
por: Nunes, Sara S., et al.
Publicado: (2013) -
Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models
por: Feaster, Tromondae K., et al.
Publicado: (2022) -
Predicting human cardiac QT alterations and pro-arrhythmic effects of compounds with a 3D beating heart-on-chip platform
por: Visone, Roberta, et al.
Publicado: (2022) -
Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment
por: Wang, Kai, et al.
Publicado: (2023) -
Blinded, Multicenter Evaluation of Drug-induced Changes in Contractility Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes
por: Saleem, Umber, et al.
Publicado: (2020)